- Trials with a EudraCT protocol (251)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
251 result(s) found for: ST segment.
Displaying page 1 of 13.
EudraCT Number: 2008-007290-20 | Sponsor Protocol Number: TMC-BIV-08-03 | Start Date*: Information not available in EudraCT | ||||||||||||||||
Sponsor Name:The Medicines Company UK Ltd. | ||||||||||||||||||
Full Title: European Ambulance Acute Coronary Syndrome Angiox Trial: EUROMAX | ||||||||||||||||||
Medical condition: Patients presenting with ST-Segment Elevation Acute Coronary Syndrome (STE-ACS) planned for a primary Percutaneous Coronary Intervention (PCI) management strategy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) AT (Completed) DK (Completed) FR (Completed) NL (Completed) CZ (Completed) ES (Completed) PL (Completed) IT (Completed) SI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-001325-34 | Sponsor Protocol Number: 17/2008/U/Sper | Start Date*: 2008-04-01 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: PROMISE AMI (PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in Acute Myocardial Infarction treated by primary PCI) Pilot Study | |||||||||||||
Medical condition: Acute myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000303-42 | Sponsor Protocol Number: 9050 | Start Date*: 2006-09-25 | |||||||||||
Sponsor Name:ISALA KLINIEKEN | |||||||||||||
Full Title: A randomized, double blind controlled trial evaluating the benefits of early up-front-loaded high dose Tirofiban in the treatment of patients with ST-segment elevation myocardial infarction, who ar... | |||||||||||||
Medical condition: acute myocardial infarction with ST segment elevation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005369-64 | Sponsor Protocol Number: iBEAST/2 | Start Date*: 2015-06-19 | |||||||||||
Sponsor Name:Consorci MAr Parc de Salut de Barcelona | |||||||||||||
Full Title: Improve the myocardial reperfusion in ST elevation myocardial infarction: a randomized study between standard percutaneous coronary intervention with thrombectomy and pharmacological approach guide... | |||||||||||||
Medical condition: ST elevation myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010295-23 | Sponsor Protocol Number: ARCARDIO002 | Start Date*: 2009-03-07 | |||||||||||
Sponsor Name:AZIENDA USL 8 AREZZO | |||||||||||||
Full Title: Load & Go trial: Safety and effectiveness of three different clopidogrel loading doses, administered at first medical contact in patients with acute myocardial infarction undergoing primary angiopl... | |||||||||||||
Medical condition: acute myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023211-34 | Sponsor Protocol Number: | Start Date*: 2011-04-27 | ||||||||||||||||
Sponsor Name:University Hospitals of Leicester NHS Trust | ||||||||||||||||||
Full Title: Randomized Controlled Trial Comparing Intracoronary Administration of Adenosine or Sodium Nitroprusside to Control for Attenuation of Microvascular Obstruction During Primary Percutaneous Coronary ... | ||||||||||||||||||
Medical condition: Acute ST-segment Elevation Myocardial Infarction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-002876-18 | Sponsor Protocol Number: 2011-002876-18 | Start Date*: 2011-12-19 | |||||||||||
Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI | |||||||||||||
Full Title: CYCLosporinE A in reperfused acute myocardial infarction (CYCLE-Trial) | |||||||||||||
Medical condition: All (male and female) patients, aged over 18, presenting with a large STEMI not older than 4 hours (defined as angina pectoris or equivalent symptoms of more than 30 minutes duration within the las... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004238-25 | Sponsor Protocol Number: 2012-004-0402-CARD | Start Date*: 2015-02-09 | |||||||||||||||||||||
Sponsor Name:The Royal Wolverhampton NHS Trust | |||||||||||||||||||||||
Full Title: Pharmacokinetics and Pharmacodynamics of Platelet P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction: A Pilot Study | |||||||||||||||||||||||
Medical condition: ST-segment elevation myocardial infarction Non ST-segment elevation myocardial infarction | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-012120-89 | Sponsor Protocol Number: CARDIOTA80-2009 | Start Date*: 2009-09-23 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: 80MG ATORVASTATIN THERAPY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PTCA | |||||||||||||
Medical condition: ST elevation Myocardial Infarct | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002547-25 | Sponsor Protocol Number: ARC1779-003 | Start Date*: 2007-12-19 | ||||||||||||||||
Sponsor Name:Archemix Corp. | ||||||||||||||||||
Full Title: A Phase 2 Study of an Aptameric von Willebrand Factor Antagonist, ARC1779, in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention | ||||||||||||||||||
Medical condition: ACS Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention (ST segemnt elevation MI and Non ST segemtn elevation MI) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) AT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008491-13 | Sponsor Protocol Number: 2008-008491-13 | Start Date*: 2009-03-07 | ||||||||||||||||||||||||||
Sponsor Name:AZIENDA USL 8 AREZZO | ||||||||||||||||||||||||||||
Full Title: A Multicentric randomized comparison between iso-osmolar and ipo-osmolar contrast agents in STEMI patients undergoing primary PCI. Assessment of contrast-induced nephropathy incidence and myocardia... | ||||||||||||||||||||||||||||
Medical condition: Patients with Acute Myocardial Infarction within 12 hours after the onset of symptoms | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003721-41 | Sponsor Protocol Number: SKS-CANTI2016 | Start Date*: 2018-03-01 | |||||||||||
Sponsor Name:Department of Cardiology, Aarhus University Hospital, Skejby | |||||||||||||
Full Title: Cangrelor versus Ticagrelor for Early Platelet Inhibition in ST-Elevation Myocardial Infarction. (The CanTi study) | |||||||||||||
Medical condition: ST-elevation Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001642-26 | Sponsor Protocol Number: LRD.2016.STREAM2 | Start Date*: 2017-10-02 | |||||||||||
Sponsor Name:Leuven Research & Development (LRD) at University of Leuven, Belgium | |||||||||||||
Full Title: STREAM-2 (STrategic Reperfusion in elderly patients Early After Myocardial Infarction) | |||||||||||||
Medical condition: ST-elevation myocardial infarction within 3 hours of onset of symptoms | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023779-24 | Sponsor Protocol Number: M10-1028 | Start Date*: 2010-12-06 |
Sponsor Name:Stichting Toegepast Caridologisch Onderzoek | ||
Full Title: A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study | ||
Medical condition: Patients with ACS who are scheduled for primary PCI (STEMI) or for immediate PCI < 2.5 hours or early PCI < 48 hours (NSTEMI) and who are pre-treated with HLD clopidogrel | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002824-42 | Sponsor Protocol Number: SPIRI-201 | Start Date*: 2012-04-17 | |||||||||||
Sponsor Name:Stealth Peptides Inc. | |||||||||||||
Full Title: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability and Efficacy of Intravenous Bendavia™ (MTP-131) on Reperfusion Injury in Patients Treated with St... | |||||||||||||
Medical condition: Reperfusion injury in ST-segment Elevation Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002813-33 | Sponsor Protocol Number: ARMYDA-9DAPAtrial | Start Date*: 2023-02-21 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA | ||||||||||||||||||
Full Title: Early use of dapaglifozin in diabetic patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 DAPA trial | ||||||||||||||||||
Medical condition: Patients with type 2 diabetes and ST-elevation myocardial infarction treated with primary primary percutaneous coronary intervention and reduced left ventricle ejection fraction. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005260-10 | Sponsor Protocol Number: 123 | Start Date*: 2013-02-11 | ||||||||||||||||
Sponsor Name:Uppsala Clinical Research Center | ||||||||||||||||||
Full Title: Bivalirudin versus Heparin in NST and ST-Evaluation myocardial infarction on modern antiplatelet therapy in SWEDEHEART (the VALIDATE - SWEDEHEART-trial) | ||||||||||||||||||
Medical condition: Patients with STEMI and NSTEMI treated with PCI and either Bivalirudin (optional to add up to 3000U heparin in lab or up to 5000U given prehospital ) compared to Heparin 70 - 100U/kg alone | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003621-36 | Sponsor Protocol Number: 20-126 | Start Date*: 2021-02-10 | |||||||||||
Sponsor Name:CHU CAEN Normandie | |||||||||||||
Full Title: Evaluation de la reperfusion myocardique et de la masse thrombotique endocoronaire après angioplastie primaire pour infarctus du myocarde sous cangrelor en intraveineux en plus du ticagrelor per os... | |||||||||||||
Medical condition: Patients admis pour angioplastie coronaire primaire (PPCI) pour infarctus du myocarde avec sus-décalage du segment ST (IDM ST+) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007676-42 | Sponsor Protocol Number: P071101 | Start Date*: 2008-04-07 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Etude ATOLL . Etude internationale, multicentrique, visant à comparer l'utilisation de l'enoxaparine IV versus héparine standard IV chez les sujets présentant un infarctus du myocarde aigu et néces... | |||||||||||||
Medical condition: infarctus aigu du myocarde avec élévation du segment ST sur le point de subir une intervention coronaire percutanée (ICP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004485-12 | Sponsor Protocol Number: 200807 | Start Date*: 2008-09-03 |
Sponsor Name:University Medical Center of Groningen | ||
Full Title: Coronary versus Intravenous abCiximab administration during Emergency Reperfusion Of ST-segment elevation myocardial infarction – the CICERO trial | ||
Medical condition: ST-segment elevation myocardial infarction (STEMI) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
